Syneos Health
(NASDAQ) SYNH
This security has been delisted. This page is retained for historical reference.
SYNH News
Will COVID-19 Derail New Drugs?
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowSYNH Financials
Key Financial Metrics (TTM)
Gross Margin
23%
Operating Margin
7%
Net Income Margin
5%
Return on Equity
8%
Return on Capital
6%
Return on Assets
3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.25B
Operating Income
$403.19M
EBITDA
$699.99M
Operating Cash Flow
$426.98M
Capital Expenditure
$93.46M
Free Cash Flow
$333.52M
Cash & ST Invst.
$112.00M
Total Debt
$2.90B
Syneos Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.37B
+0.4%
Gross Profit
$294.72M
-9.6%
Gross Margin
21.57%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
28,768
N/A
Net Income
$793.00K
-99.0%
EBITDA
$97.87M
-47.7%
Quarterly Fundamentals
Net Cash
$2.81B
+6.3%
Accounts Receivable
$1.70B
+5.8%
Inventory
$109.00K
+0.9%
Long Term Debt
$2.83B
-7.1%
Short Term Debt
$68.27M
+6.5%
Return on Assets
3.25%
N/A
Return on Invested Capital
6.23%
N/A
Free Cash Flow
$51.64M
-168.4%
Operating Cash Flow
$33.68M
-133.7%